NCT06010875View on ClinicalTrials.gov

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

September 30, 2026

Conditions
Renal Cell CarcinomaOvarian CancerCervix CancerMetastatic CancerAdvanced Cancer
Interventions
BIOLOGICAL

CD70 CAR-T cells

After lymphodepletion with Fludarabine and Cyclophosphamide,CAR T cells were transfused intravenically

BIOLOGICAL

CD70 CAR-T cells

After lymphodepletion with Fludarabine and Cyclophosphamide,CAR T cells were injected intraperitoneally

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital of Nanchang University, Nanchang

All Listed Sponsors
collaborator

The First Affiliated Hospital of Nanchang University

OTHER

lead

Chongqing Precision Biotech Co., Ltd

INDUSTRY